Acasti Pharma reported CAD0 in Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Acasti Pharma ACST:US C$ 0M 0M
Addus Homecare ADUS:US $ 220.71M 26.02M
Agile Therapeutics AGRX:US $ 16.43M 0.4M
Amarin AMRN:US $ 0M 0M
Bioscrip BIOS:US $ 1129.6M 1.64M
Genetic Technologies GENE:US $ 204.04K 162.95K
Pain Therapeutics PTIE:US $ 0M 0M